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INTRODUCTION
Autologous fat grafting has become a widely used tool 
in plastic surgery for tissue augmentation and for restor-
ing volume defects.1–5 Major differences in graft reten-
tion (10–90%) has been reported over the years,6–10 but 
extensive research and increasing experience with the 
technique has resulted in improved and more consistent 
graft retentions in recent reports.11 Despite this, the quest 
for improving fat graft retention even further continues 
and enriching fat grafts with either stromal vascular frac-
tion (SVF) cells12–17 or ex vivo expanded adipose-derived 
stromal/stem cells (ASCs)18,19 have shown promising re-
sults. However, many questions regarding the mechanism 
of action and fate of ASCs remain unclear, and the opti-
mal concentration and most effective cellular enrichment 
composition are unknown. To answer these questions, an 
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Background: Cell-enriched fat grafting has shown promising results for improving 
graft survival, although many questions remain unanswered. A large animal model 
is crucial for bridging the gap between rodent studies and human trials. We pres-
ent a step-by-step approach in using the Göttingen minipig as a model for future 
studies of cell-enriched large volume fat grafting.
Methods: Fat grafting was performed as bolus injections and structural fat grafting. Graft 
retention was assessed by magnetic resonance imaging after 120 days. The stromal vas-
cular fraction (SVF) was isolated from excised fat and liposuctioned fat from different 
anatomical sites and analyzed. Porcine adipose-derived stem/stromal cells (ASCs) were 
cultured in different growth supplements, and population doubling time, maximum 
cell yield, expression of surface markers, and differentiation potential were investigated.
Results: Structural fat grafting in the breast and subcutaneous bolus grafting in the 
abdomen revealed average graft retention of 53.55% and 15.28%, respectively, which 
are similar to human reports. Liposuction yielded fewer SVF cells than fat excision, 
and abdominal fat had the most SVF cells/g fat with SVF yields similar to humans. 
Additionally, we demonstrated that porcine ASCs can be readily isolated and expand-
ed in culture in allogeneic porcine platelet lysate and fetal bovine serum and that the 
use of 10% porcine platelet lysate or 20% fetal bovine serum resulted in population 
doubling time, maximum cell yield, surface marker profile, and trilineage differen-
tiation that were comparable with humans.
Conclusions: The Göttingen minipig is a feasible and cost-effective, large animal 
model for future translational studies of cell-enriched fat grafting. (Plast Recon-
str Surg Glob Open 2018;6:e1735; doi: 10.1097/GOX.0000000000001735; Published 
online 4 April 2018.)
Supplemental digital content is available for this 
article. Clickable URL citations appear in the text.
Copyright © 2018 The Authors. Published by Wolters Kluwer Health, 
Inc. on behalf of The American Society of Plastic Surgeons. This 
is an open-access article distributed under the terms of the Creative 
Commons Attribution-Non Commercial-No Derivatives License 4.0 
(CCBY-NC-ND), where it is permissible to download and share the 
work provided it is properly cited. The work cannot be changed in 
any way or used commercially without permission from the journal.
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animal model with fat volume and composition similar to 
humans is needed.
Most previous animal studies have used xenogeneic 
models with human cells and fat tissue grafted in very 
small volumes into immune-deficient rodents,20,21 which 
is far from the clinical setting. Therefore, an intermedi-
ate large animal model with superior comparability to 
humans and the option of studying larger volumes of fat 
grafts is imperative.
No such model currently exists, and therefore, we de-
cided to investigate and validate the Göttingen minipig 
for future studies of cell-enriched fat grafting due to the 
similarities between these pigs and humans in terms of 
anatomy and pathophysiology.22,23 Regarding the scope of 
fat grafting, an important factor is that Göttingen minipigs 
build up a thick subcutaneous fat layer when fed to obesi-
ty, which is essential for performing standard large-volume 
liposuction. Additionally, obese Göttingen minipigs weigh 
no more than 60–70 kg, which allows for handling during 
surgery and magnetic resonance imaging (MRI). Finally, 
these minipigs are widely used experimental animals in 
other fields of research.24,25
The primary aim of this study was to investigate the 
efficacy and translatability of the Göttingen minipig as 
an animal model for future studies of autologous cell-en-
riched fat grafting of larger volumes. We therefore per-
formed feasibility studies of both the in vitro and in vivo 
aspects of the technique and compared the obtained data 
with existing human data on ASC expansion and autolo-
gous fat grafting. We investigated:
1)  SVF isolation from excised fat versus liposuction 
from different anatomical sites;
2)  large volume liposuction and conventional fat 
grafting (nonenriched) via both bolus injection 
and structural fat grafting;
3)  fat graft retention assessed by MRI at day 120;
4)  ASC cultures with different growth supplements 
[fetal bovine serum (FBS), pooled porcine plate-
let lysate (pPPL), pooled human platelet lysate 
(pHPL), and porcine serum (PS)] with respect to 
population doubling time (PDT), maximum cell 
yield, expression of surface markers, and differen-
tiation potential; and
5)  the feasibility of ASC expansion for large-volume 
cell-enriched fat grafting.
MATERIALS AND METHODS
Animals
Adult female Göttingen minipigs weighing approxi-
mately 70 kg were used in accordance with The Danish 
Animal Experiments Inspectorate, permission 2015-15-
0201-00681.
Harvesting of Fat for SVF Isolation: Techniques and 
Anatomical Sites
To identify the effect of different harvesting tech-
niques and different donor sites on SVF yield, we per-
formed syringe-aspiration and surgical excision of adipose 
tissue from the neck, back, and abdomen. Fifty milliliters 
of lipoaspirate and 20 grams of excised fat were harvested 
from all 3 donor sites, and the SVF yield was determined 
by cell counting.
Large Volume Liposuction and Fat Grafting
A GID-700 canister was used for collecting and washing 
the lipoaspirate. Tumescent solution was installed before 
suction-assisted liposuction, which was performed with a 
pressure no lower than -0.6 bar. The temperature in the 
canister was kept above 30°C to prevent solidification of 
the lipoaspirate. Fat grafting was performed with either 
a subcutaneous bolus injection of 30 mL lipoaspirate in-
jected on the abdomen of the animal (n = 4) or via a struc-
tural fat grafting technique using a fat graft of 150–185 mL 
injected into the pig’s breast (n = 4).
Magnetic Resonance Imaging
Volume retention of the bolus fat grafts was calcu-
lated as described previously26 directly after grafting and 
again after 120 days. A region of interest (ROI) was drawn 
around the bolus graft on all slices (Fig. 1). ROIs were 
then multiplied by slice thickness and summed to deter-
mine the overall graft volume.
Volume retention of the porcine breast was measured 
as described previously.27 First, the cranial/caudal and 
lateral/medial border of the breast were outlined on the 
image acquired directly after grafting. The cranial/cau-
dal borders were translated to a fixed distance from the 
nipple of the grafted breast, and the lateral border was 
translated into a fixed distance from the midline. The dis-
tances from these fixed pointers were noted and used on 
the subsequent scan after 120 days (Fig. 2).
Isolation and Culture of ASCs
The tissues were incubated with collagenase type 
4 at 37°C with constant rotation for 90 minutes before 
neutralizing with culture medium (CM) consisting of 
Dulbecco’s modified Eagle’s medium, 1% penicillin-
streptomycin, and 10% FBS. The suspension was filtered 
(100-µm filter) and centrifuged at 1,200 g for 10 minutes. 
The pellet was resuspended in CM and seeded in 75 cm2 
culture flasks with 10,000 cells/cm2. Cells were cultured 
at 37°C in an atmosphere of 5% carbon dioxide and 
humidified air. The CM was changed every 3–4 days. At 
confluence, cells were passaged using TrypLE Select 1X 
for 20 minutes at 37°C, neutralized with CM, and centri-
fuged at 300 g for 6 minutes. The pellet was resuspended 
and reseeded.
Culture Expansion of ASCs for Large-volume Fat Grafting
Up to 350 mL of lipoaspirate was incubated with col-
lagenase at 37°C for 90 minutes while shaken at 140 rpm. 
The suspension was neutralized with CM, filtered (200-
µm filter) and centrifuged at 1,200 g for 10 minutes. The 
pellet was resuspended in CM, and cells were seeded in 
one 6,320 cm2 10-layer Cell Factory at densities of 20,000–
40,000 cells/cm2. The CM, which contained 20% FBS, was 
changed only once on day 6, and at 90–100% confluence 
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(day 14), the cells were passaged and reseeded in three 
8,216 cm2 13-layer Cell Factory’s at densities of 20,000–
30,000 cells/cm2 without changing the CM (according to 
unpublished data) for 1 additional week.
Production of Pooled Human Platelet Lysate
pHPL was produced as described previously18,28 by us-
ing otherwise discarded outdated platelet concentrates 
initially intended for human use.
Fig. 1.  mr images and delineation of the rOi (subcutaneously implanted bolus fat graft). a, immediate postgrafting mr images. D, the same 
areas on day 120. the inset images (B, C, E and F) show the graft areas magnified with and without delineation for reference. mr, magnetic 
resonance.
Fig. 2. mr images with delineation of the rOi (large-volume structural fat graft in the breast area of the 
pig). this example pig received bilateral structural fat grafting. a, immediate postgrafting mr images. 
B, the same areas on day 120. note the nipple, which serves as a reference point for setting the cranial/
caudal borders. mr, magnetic resonance.
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Production of Pooled Porcine Platelet Lysate
Blood from exsanguinated slaughter pigs was collected 
and separated by centrifugation and leukocyte depletion 
filtration before a freeze/thaw cycle for the lysis and re-
lease of growth factors. pPPL was pooled and sterile fil-
tered before storing at ˗80°C.
Proliferation Assay
ASCs were isolated and cultured 2 passages in CM 
supplemented with 1 of 5 growth supplements: 10% FBS, 
20% FBS, 10% pPPL, 10% pHPL, or 10% PS. Cells were 
seeded in 25 cm2 flasks with 5,000 cells/cm2, and the CM 
was changed every fourth day. One flask from all cell lines 
was collected and counted in technical triplicates every 
other day.
The yields were plotted with time on a linear x axis 
and cell densities on a base 10 logarithmic y axis. Semi-
logarithmic fit lines were fitted to the linear growth phase 
(ie, the log phase) by means of the least-squares methods.
The PDT was calculated using the formula: PDT = (t2 
˗ t1) · log(2)/(log(final cell density at t2) ˗ log(initial cell 
density at t1)), where t1 is the beginning of the log phase, 
and t2 is the end of the log phase as defined by the fit 
lines.
Trilineage Differentiation
ASCs were cultured to passage 5 in CM containing 
10% FBS, 20% FBS, 10% pHPL, 10% pPPL, or 10% PS 
and then induced to trilineage differentiation using a 
STEMPRO Differentiation Kit. Cells were cultured for 14 
or 21 days before staining for adipogenic, osteogenic, and 
chondrogenic differentiation.
Flow Cytometry
ASCs cultured with each of the 5 different growth sup-
plements were phenotypically characterized using flow 
cytometry with anti-CD44, anti-CD90, anti-CD105, and 
anti-CD45 antibodies. Fluorescence minus one staining 
served as controls.
Statistical Analysis
Statistical analysis was performed using SAS Enterprise 
Guide 7.1, and graphs were generated in Prism 7. A 2-way 
analysis of variance (ANOVA) was used for comparing dif-
ferences in SVF cell yields between different harvest tech-
niques and donor sites with Tukey’s multiple comparisons 
test used for post hoc analysis. To compare the total cell 
yield in the proliferation assay and differences in the PDTs, 
1-way ANOVA was performed with Bonferroni-adjusted P 
values. The normal distribution of all groups was assessed 
by the Shapiro-Wilk test, and a 2-sided P value of < 0.05 was 
considered statistically significant. All data are presented 
as the mean ± SD.
RESULTS
Harvest Techniques and Donor Sites
The SVF cell yield obtained by surgical excision was 
significantly higher than that obtained by liposuction in 
all 3 donor sites (P ≤ 0.026). In addition, the number 
of SVF cells obtained by liposuction from the abdomen 
was significantly higher than that obtained from the back 
(P = 0.043), as shown in Figure 3. For histological features 
of the 3 donor sites, see Supplemental Digital Content 1 
(see figure, Supplemental Digital Content 1, which dis-
Fig. 3. the mean SVF cells/g fat obtained by syringe liposuction from the back, neck, and abdo-
men regions were 4.92 × 105 ± 1.96 × 105, 6.08 × 105 ± 0.75 × 105, and 7.72 × 105 ± 2.10 × 105 SVF cells/g 
fat, respectively, and those obtained by surgical excision were 9.93 × 105 ± 2.32 × 105, 10.8 × 105 ± 
2.82 × 105, and 11.4 × 105 ± 3.40 × 105 SVF cells/g fat, respectively (n = 4). in contrast, as shown in table 
1, suction-assisted liposuction from the abdomen in larger volumes yielded a mean of 9.95 × 105 SVF 
cells/g fat. this difference could be explained by the different harvesting techniques, but most likely 
because the pigs undergoing syringe liposuction were exsanguinated before the procedure, and 
thus, a smaller amount of blood cells were mixed with the lipoaspirate, that is, in the SVF.
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plays histological features of the different donor sites, 
http://links.lww.com/PRSGO/A741).
Fat Grafting and Volume Retention Calculated from MRI
MRI revealed that the initial volume of the 4 bolus 
grafts was 30.22 ± 0.78 mL, corresponding well to the in-
jected volumes. On day 120, the average residual vol-
ume was 4.61 ± 0.96 mL, demonstrating graft retention of 
15.28 ± 3.31% of the initial volume.
The average retention of the 4 structural fat grafts was 
53.55 ± 1.95% (Figs. 1, 2).
For histology of the different fat grafts before and 120 
days after grafting see Supplemental Digital Content 2 
(see figure, Supplemental Digital Content 2, which dis-
plays histology of the fat grafts before and 120 days after 
grafting, http://links.lww.com/PRSGO/A742).
Isolation and Culture of ASCs
ASCs cultured in pPPL, 10% FBS, and 20% FBS ap-
peared elongated and spindle shaped and reached com-
plete confluence without losing their plastic adherent 
properties as seen in Figure 4. ASCs cultured with PS 
initially displayed the same appearance but turned into 
large spheres with low adherence, whereas ASCs cultured 
in pHPL were smaller, less elongated, more pellucid, and 
less adherent to the plastic surface. See full figure of the 
cell morphology in Supplemental Digital Content 3 (see 
figure, Supplemental Digital Content 3, which displays 
full figure of the cell morphology, http://links.lww.com/
PRSGO/A743).
Large-volume Culture Expansion
The average amount of fat used in large-volume SVF 
isolation was 260 g, but 1,000–1,500 g could be easily ob-
tained by liposuction. The average yield of isolated SVF was 
9.95 × 105 ± 3.14 × 105 SVF-cells/g fat. Subsequent culture 
expansion for 3 weeks resulted in an average of 1.63 × 109 ± 
0.32 × 109 total ASCs per sample, equivalent to an increase 
by more than 1,600 times. Details are given in Table 1.
Trilineage Differentiation Assay
All ASCs could differentiate into adipocytes, chondro-
cytes, and osteocytes regardless of the growth supplement 
used for culture as seen in Figure 5 and the full figure of 
trilineage differentiation(see figure, Supplemental Digital 
Content 4, which displays full figure of trilineage differen-
tiation, http://links.lww.com/PRSGO/A744).
Flow Cytometry
ASCs cultured in 10% FBS, 20% FBS, pPPL, and PS 
were positive for CD44, CD90, and CD105, although cells 
cultured in 10% PS appeared to have a slightly lower ex-
pression of CD44. In contrast, ASCs cultured in pHPL were 
negative for CD105 and exhibited reduced expression of 
CD90 and CD44. All cells were negative for CD45 regard-
less of the CM used (see figure, Supplemental Digital Con-
tent 5, which displays Figure of the phenotypic analysis by 
flow cytometry, http://links.lww.com/PRSGO/A745).
Proliferation Assay
All cells showed an initial lag phase of growth for ap-
proximately 2 days. For the ASCs cultured in 20% FBS, 
Fig. 4. aSC morphology in pppl cultured cells. populations of plastic adherent, aSCs occurred from 
both lipoaspirate and excised adipose tissue with an elongated, spindle shaped appearance. after pas-
sage and reseeding with 5,000 cells/cm2, confluency was reached after 5–7 days with the use of 10% 
pppl. these aSCs also had the ability to become “overconfluent” before reaching replicative senes-
cence. magnification: 10× original magnification. For full figure of the aSC morphology, see Supple-
mental Digital Content 3.
Table 1.  Data for ASC Culture Expansion in 6 Minipigs
Pig Fat (g) SVF Cells/g Fat Viability (%) Seeding SVF/cm2 Harvested P0 ASCs Seeding P1/cm2 Harvested P1 ASCs
1 190 9.21 × 105 67 2.8 × 104 7.62 × 108 3.0 × 104 1.50 × 109
2 300 13.30 × 105 88 3.7 × 104 8.23 × 108 3.3 × 104 1.26 × 109
3 250 9.87 × 105 76 3.9 × 104 8.76 × 108 3.0 × 104 2.16 × 109
4 200 13.97 × 105 69 4.4 × 104 7.88 × 108 3.2 × 104 1.72 × 109
5 230 6.57 × 105 69 2.3 × 104 5.13 × 108 2.1 × 104 1.38 × 109
6 390 6.82 × 105 71 2.1 × 104 5.32 × 108 2.2 × 104 1.77 × 109
Mean; SD 260; 74.8 9.95 × 105; 3.14 × 105 73; 7.82 3.2 × 104; 0.94 × 104 7.16 × 108; 1.55 × 108 2.8 × 104; 0.53 × 104 1.63 × 109; 0.32 × 109
SVF was harvested by suction-assisted liposuction and cultured for 14 days before reseeding and culturing for an additional week. Growth supplement used: 20% FBS.
P0, passage zero; P1, passage one.
6PRS Global Open • 2018
pPPL, and pHPL, the lag phase was followed by a short 
log phase of growth for 4–5 days before reaching a plateau 
around days 6–8. The ASCs cultured in 10% FBS and PS 
showed a longer log phase of growth for approximately 
8–10 days before reaching a plateau around days 10–14. 
There was no significant difference in PDT between ASCs 
cultured in 20% FBS, pPPL, or pHPL, but the PDTs were 
significantly shorter compared with ASCs cultured in 10% 
FBS and PS (P < 0.05; Fig. 6).
During the plateau phase (approximately days 16–28), 
ASCs cultured in 20% FBS exhibited the highest maxi-
mum yield of 17.7 × 104 ± 0.94 × 104 ASCs/cm2, correspond-
ing to approximately 340% more ASCs than those grown 
in PS. There was also a 250% increase in ASCs grown in 
20% FBS compared with those grown in 10% FBS (Fig. 7).
DISCUSSION
Porcine ASCs have previously been isolated and char-
acterized from excised fat tissue.29–31 However, contrary to 
previous animal studies where graft volumes have seldom 
exceeded 1 mL,20,21 the development of a translational 
model for clinically relevant fat grafting of larger volumes 
requires the use of lipoaspirate instead of excised fat.
No previous studies have reported isolation of porcine 
ASCs from large-volume lipoaspirates. We were able to ex-
tract 1,000–1,500 mL of lipoaspirate with little effort and 
no surgical complications.
In large-volume SVF isolations acquired by suction-
assisted liposuction, we demonstrated an average yield of 
9.95 × 105 ± 3.14 × 105 live SVF cells/g adipose tissue. This 
amount of SVF cells correlates to results from human stud-
ies in which the average SVF yield has been reported to 
range from 7.19 × 105 to 9.55 × 105 live cells/g adipose tis-
sue.32–34 In addition, similar to previous human studies, 
we demonstrated a significantly higher SVF yield from 
adipose tissue harvested by surgical excision compared 
with liposuction,35–37 and a higher density of SVF cells in 
the lipoaspirate from the abdomen compared with the 
back.35,38,39
To our knowledge, this is also the first report of struc-
tural fat grafting into the breast area of Göttingen minip-
igs. This specific recipient site and technique of structural 
fat graft injection were chosen to mimic the gold standard 
of clinical fat grafting in humans. After 120 days, we found 
a mean residual volume of 53.55%, which is comparable 
with humans where residual volumes of 38.1–54% have 
been reported in prospective, controlled clinical studies 
with no preconditioning of the recipient site.12,13,17,27,40,41 
We also investigated subcutaneous bolus injections of 30-
mL fat grafts and found an average residual volume of 
15.28% similar to the 16.3% reported in the only previous 
human study that employed this technique.18
For large-volume ASC-enriched fat grafting to be fea-
sible in a clinical setting, it is imperative to obtain a suf-
ficient number of cells within an acceptable timeframe. 
Additionally, regarding translational tissue, PDTs similar 
to human studies may hold promising biological signifi-
cance. Because studies of human ASCs have repeatedly 
identified human platelet lysates as superior to FBS for 
ensuring fast and reproducible culture expansion and 
because animal-based growth supplements are associated 
with the risk of xeno-immunization and transmission of 
animal pathogens,42–48 we tested both FBS, pHPL, and al-
logeneic alternatives, that is, pPPL and PS.
Porcine ASCs have previously been cultured in au-
tologous porcine platelet lysate,49 which cannot be pro-
duced in the quantities needed for large-volume culture 
expansion. We present for the first time a feasible and 
cost-effective method to produce allogeneic pPPL. Mini-
pigs and domestic pigs are considered the same species, 
and therefore, the blood from both animals can be used 
to produce pPPL. This is advantageous, as large quantities 
of blood can be collected from slaughter pigs and used to 
culture ASCs from minipigs. Pigs and humans have similar 
platelet counts in the range of 150–500 × 109/l50,51; however, 
porcine platelets are smaller, why the centrifugation force 
and time for production of Platelet Rich Plasma are differ-
ent, in addition to leucocyte filtration. We found that pPPL 
provided the shortest PDT (26.48 hours) and was corre-
lated with culture expansion of human ASCs, for which 
the use of pHPL also conferred shorter PDTs compared 
with FBS.42,43,52,53 Additionally, the total pPPL cell density 
of 1.21 × 105 at the plateau was comparable with studies of 
human ASCs in which cell densities at the plateau phase 
were reported in the range of 1.50 × 105 ASC/cm2 with the 
use of 10% pHPL.26,42 However, FBS remains the standard 
Fig. 5. Differentiation capacity of porcine aSCs. Cells were expanded in culture with 5 different growth 
supplements before trilineage differentiation was induced. Oil red O, alcian Blue, and alizarin red S 
staining were used to visualize lipid vacuoles, proteoglycans and calcium complexes, respectively. Here 
only aSCs cultured in pppl are shown. For the full figure, see Supplemental Digital Content 4. ad-
ipogenic differentiation: 20× original magnification. Chondrogenic and osteogenic differentiation: 10× 
original magnification.
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growth supplement for culturing ASCs in animal studies, 
and growth rates and cell densities comparable with those 
from 10% pPPL could be achieved with the use of 20% 
FBS, as shown in Figures 6, 7. The differentiation potential 
and surface marker profiles for culture in pPPL and 20% 
FBS were not significantly different, indicating that they 
are equally translatable to human data. Additionally, 20% 
FBS produced the highest total cell density at the plateau 
Fig. 6. Growth curves of aSCs cultured in different growth supplements (n = 3). the fit lines were calculated with the following formula: 
y = 10ax + b (where a is the slope, and b is the intercept), with x = (log10[y] – b) / a. lower right: the mean cell density of all growth supple-
ments over time.
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phase with 1.77 × 105 ASC/cm2, which can be advantageous 
if large-volume ASC expansion is needed. Moreover, FBS is 
readily obtainable from commercial suppliers.
Porcine ASCs have previously been characterized,29,54,55 
and in particular, Casado et al.30 reported their characteriza-
tion including mesenchymal stem cell markers (CD29, CD44, 
CD45, CD90, and CD105), histocompatibility molecules 
(SLA-I and SLA-II), and cell adhesion molecules (CD11a, 
CD11b, CD18, and CD61), revealing that porcine ASCs are 
similar to human ASCs. In the present study, we show that 
cells isolated and expanded in culture had CD44+, CD90+, 
CD105+, and CD45− phenotypes when cultured in alloge-
neic serum/platelet lysate or FBS. In contrast, cells cultured 
in the xenogeneic pHPL showed a marked reduction in the 
surface expression of CD44 and CD90 and were negative for 
CD105, indicating possible alteration of the cells. Nonethe-
less, we found that the porcine ASCs were able to differenti-
ate into adipogenic, chondrogenic, and osteogenic lineages 
regardless of the growth supplement used for expansion.
To summarize the in vitro studies, we found that 
porcine ASCs cultured in either 10% pPPL or 20% FBS 
demonstrated morphologies, growth patterns, PDTs, max-
imum cell densities, surface markers, and differentiation 
capacities that were comparable with human ASCs cul-
tured in pHPL.
CONCLUSIONS
In this study, we have presented a novel large-animal mod-
el tailored to investigate cell-enriched fat grafting in clinically 
relevant volumes, using the Göttingen minipig. We highlight 
the many similarities between the minipig model and humans 
in terms of the fat harvest technique, donor sites, SVF cell 
yield, fat graft retention rates measured with MRI, ASC pro-
liferation capacities, surface marker profiles, and differentia-
tion capabilities. We have proven that the Göttingen minipig 
is a feasible large-animal model suitable as a solid alternative 
for future studies of cell-enriched fat grafting of larger vol-
umes. The Göttingen minipig may thus be used to bridge the 
gap between rodent models and humans to accelerate the 
translation of stem cell technology to clinical practice.
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